Stocks and Investing
Stocks and Investing
Tue, June 4, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, June 3, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Liana Moussatos Maintained (ASND) at Buy with Increased Target to $223 on, Jun 3rd, 2019
Liana Moussatos of Wedbush, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $219 to $223 on, Jun 3rd, 2019.
Liana has made no other calls on ASND in the last 4 months.
There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with Liana's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Liana
- Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $144 on, Friday, May 31st, 2019
- Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $139 on, Friday, March 29th, 2019